Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.

The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023. 

Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications.

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.

The program recognizes “the critical role of facilities providing care to patients with congenital heart disease who transition their care from pediatric cardiology to adult cardiology services.”

She will serve as the 11th chair of the Department of Medicine and system physician-in-chief for Vanderbilt Health. Her appointment was effective Jan. 1.

As in prior years, the success of Vanderbilt Health’s transplant program is a testament to the greatness of individuals and innovations alike and to the tremendous power of teamwork.